Self-reported responsiveness to direct-to-consumer drug advertising and medication use: results of a national survey
Open Access
- 23 September 2011
- journal article
- Published by Springer Nature in BMC Health Services Research
- Vol. 11 (1) , 232
Abstract
Background: Direct-to-consumer (DTC) marketing of pharmaceuticals is controversial, yet effective. Little is known relating patterns of medication use to patient responsiveness to DTC. Methods: We conducted a secondary analysis of data collected in national telephone survey on knowledge of and attitudes toward DTC advertisements. The survey of 1081 U.S. adults (response rate = 65%) was conducted by the Food and Drug Administration (FDA). Responsiveness to DTC was defined as an affirmative response to the item: "Has an advertisement for a prescription drug ever caused you to ask a doctor about a medical condition or illness of your own that you had not talked to a doctor about before?" Patients reported number of prescription and over-the-counter (OTC) medicines taken as well as demographic and personal health information. Results: Of 771 respondents who met study criteria, 195 (25%) were responsive to DTC. Only 7% respondents taking no prescription were responsive, whereas 45% of respondents taking 5 or more prescription medications were responsive. This trend remained significant (p trend .0009) even when controlling for age, gender, race, educational attainment, income, self-reported health status, and whether respondents "liked" DTC advertising. There was no relationship between the number of OTC medications taken and the propensity to discuss health-related problems in response to DTC advertisements (p = .4). Conclusion: There is a strong cross-sectional relationship between the number of prescription, but not OTC, drugs used and responsiveness to DTC advertising. Although this relationship could be explained by physician compliance with patient requests for medications, it is also plausible that DTC advertisements have a particular appeal to patients prone to taking multiple medications. Outpatients motivated to discuss medical conditions based on their exposure to DTC advertising may require a careful medication history to evaluate for therapeutic duplication or overmedication.Keywords
This publication has 17 references indexed in Scilit:
- Racial and ethnic disparities in response to direct-to-consumer advertisingAmerican Journal of Health-System Pharmacy, 2010
- FDA Direct-to-Consumer Advertising for Prescription Drugs: What Are Consumer Preferences and Response Tendencies?Health Marketing Quarterly, 2007
- A Decade of Direct-to-Consumer Advertising of Prescription DrugsNew England Journal of Medicine, 2007
- Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid usersPharmacoepidemiology and Drug Safety, 2006
- Distinguishing characteristics of patients who seek more information or request a prescription in response to direct-to-consumer advertisements☆Research in Social and Administrative Pharmacy, 2005
- Influence of Patients’ Requests for Direct-to-Consumer Advertised AntidepressantsJAMA, 2005
- Direct-to-Consumer Pharmaceutical AdvertisingArchives of internal medicine (1960), 2004
- Physicians Report On Patient Encounters Involving Direct-To-Consumer AdvertisingHealth Affairs, 2004
- Cancer Vaccines: Training the Immune System to Fight CancerFDA Consumer, 2004
- Direct-to-consumer prescription drug advertising and the publicJournal of General Internal Medicine, 1999